Skip to main content
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
    • Policies
    • Fellowship
    • Careers
  • Projects
    • Column 1
      • Animal Health & Veterinary Medicine
        • Antimicrobial Use in Food Animals
        • Cross-Sectoral Health Threats
        • Industry SWOT Analysis
      • Expanded Access
        • E-request App
        • Navigator
        • Resources for COVID-19
      • FDA Patient Listening Sessions
      • Food & Nutrition
        • About
        • Food Traceability
        • Healthy Rule Roundtables
        • Nutrition Facts Label
        • Produce Safety Stakeholder Dialogue
        • Retail Dietitian Toolkit
    • Column 2
      • Improving Access to FDA Information
        • Understanding FDA & FDA-Regulated Products
        • Improving Access to Publicly Available FDA Information
      • Research
        • About
        • IMEDS
          • IMEDS Inquiry
        • Post Market Research
        • RAISE
        • Real World Data
        • Regulatory Science Accelerator
      • Substance Use Disorders
  • News and Events
    • Innovations in Regulatory Science & Policy Awards
    • 2025 Annual Public Meeting
    • Events
    • News
    • Publications
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
      1. Board of Directors
      2. Our Staff
      3. Annual Reports
      4. Policies
      5. Fellowship
      6. Careers
  • Projects
      1. Column 1
        1. Animal Health & Veterinary Medicine
          1. Antimicrobial Use in Food Animals
          2. Cross-Sectoral Health Threats
          3. Industry SWOT Analysis
        2. Expanded Access
          1. E-request App
          2. Navigator
          3. Resources for COVID-19
        3. FDA Patient Listening Sessions
        4. Food & Nutrition
          1. About
          2. Food Traceability
          3. Healthy Rule Roundtables
          4. Nutrition Facts Label
          5. Produce Safety Stakeholder Dialogue
          6. Retail Dietitian Toolkit
      2. Column 2
        1. Improving Access to FDA Information
          1. Understanding FDA & FDA-Regulated Products
          2. Improving Access to Publicly Available FDA Information
        2. Research
          1. About
          2. IMEDS
          3. Post Market Research
          4. RAISE
          5. Real World Data
          6. Regulatory Science Accelerator
        3. Substance Use Disorders
  • News and Events
      1. Innovations in Regulatory Science & Policy Awards
      2. 2025 Annual Public Meeting
      3. Events
      4. News
      5. Publications
  • Expanded Access eRequest

ANalyzing Olfactory Dysfunction Mechanisms In COVID-19

  • Read more about ANalyzing Olfactory Dysfunction Mechanisms In COVID-19

Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection

  • Read more about Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection

Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome

  • Read more about Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome

Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

  • Read more about Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence

  • Read more about Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence

COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children

  • Read more about COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children

COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic

  • Read more about COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic

Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS

  • Read more about Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

  • Read more about NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a

  • Read more about Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 254
  • Page 255
  • Page 256
  • Page 257
  • Current page 258
  • Page 259
  • Page 260
  • Page 261
  • Page 262
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
admin@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA